Overexpression or activation of insulin-like growth factor I receptor (IGF-IR) has been observed in many human cancers including breast, lung, colon and gastric carcinomas. We demonstrate that inhibition of the endogenous insulin-like growth factor I receptor by stable expression of a dominant-negative IGF-IR represses the transforming activity in vitro and tumorigenicity of human lung carcinoma cells A549 in vivo. The suppression of tumorigenicity in nude mice is correlated with the induction of glandular dierentiation. In addition, functional inhibition of the endogenous receptor dramatically increases the sensitivity of A549 cells to a variety of apoptotic signals including UV irradiation and proteasome inhibitors. These eects are due to the formation of a stable heterocomplex of the dominant-negative receptor with the endogenous wild type receptor which reduces the kinase activity of the latter by twofold. Thus, inhibition of the IGF-IR signaling pathway not only suppresses tumorigenicity but also enhances sensitivity to apoptosis-inducing agents. Antagonizing IGF-IR signaling by promoting tumor dierentiation and enhancing sensitivity to apoptotic death are potential cancer therapeutic approaches.
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Keywords: IGF-IR; glandular dierentiation; lung carcinoma cells Insulin-like growth factor I receptor (IGF-IR) is a receptor protein tyrosine kinase (RPTK) expressed in a wide variety of cell types including mesenchymal, epithelial, and hematopoietic cells. The receptor is a transmembrane heterotetramer consisting of two a subunits and two b subunits linked by disul®de bonds. Binding of IGF-I to its receptor results in receptor oligomerization, activation of PTK, intermolecular receptor autophosphorylation and phosphorylation of cellular substrates that consequently lead to gene activation, DNA synthesis and cell proliferation (Yarden and Ullrich, 1988; Williams, 1989; Cantley et al., 1991; Schlessinger, 1988; Yarden and Schlessinger, 1987) .
Activation of IGF-IR appears to be potent in stimulating DNA synthesis and cell growth (Randazzo et al., 1990; Le Roith, 1995) , and is strongly associated with cell transformation both in vitro and in vivo . IGF-IR has been found to be overexpressed in various human cancers including breast, lung, gastric and colon . In many tumor cells including non-small cell and small cell lung carcinomas, and mesotheliomas, a high level of expression of IGF-IR and IGF-I can act in an autocrine fashion (Macauley et al., 1988; Freed and Herinton, 1989; Nakanishi et al., 1988; Lee et al., 1993) . When IGF-IR was overexpressed in NIH3T3 cells, rat ®broblasts, and chicken embryo ®broblasts, neoplastic phenotypes were observed in a liganddependant manner as demonstrated by growth in soft agar and in vivo tumor formation (Kaleko et al., 1990; Liu et al., 1993) . The importance of IGF-IR in tumor development has also been implicated by the fact that the kinase activity of IGF-IR is essential for the transforming activity of other cellular and viral oncogenes including EGFR, SV40 large T antigen, constitutively activated Ras, Raf and v-Src Copola et al., 1994; Valentinis et al., 1997) . In addition, expression of antisense mRNA for the receptor inhibited the growth of cancer cells derived from human glioblastoma, melanoma, ovarian carcinoma, rhabdomyosarcoma and breast cancer Neuenshwander et al., 1995; Rininsland et al., 1997; Resnico et al., 1994; Resnico et al., 1995) . The fact that a decrease in receptor number causes tumor cells to lose the ability to form colonies in soft agar and tumors in animals strongly supports the role of IGF-IR in the establishment and maintenance of the transformed phenotype.
Relevant to the role of IGF-IR in tumorigenesis is its anti-apoptotic function. IGF-IR has been shown to protect tumor cells from apoptosis in vivo (Kulik et al., 1997) . Overexpression of IGF-IR protects cells from UV irradiation-, cytokine-and gamma radiationinduced apoptosis (Kulik et al., 1997; Nakamura et al., 1997; Turner et al., 1997; D'Ambrosio et al., 1997; Wu et al., 1996) . Conversely, expression of a kinasede®cient mutant of the receptor or treatment with antisense oligonucleotides increased the sensitivity to cell death induced by several stimuli (Kulik et al., 1997) .
It was ®rst reported by Prager et al. (1994) that a mutant containing a carboxyl-terminus deletion starting from amino acid 952 in the b subunit of IGF-IR (952STOP) functions in a dominant-negative manner in rat cells. In accord with this observation, we constructed the same deletion mutant, and tagged it with an HA epitope at the carboxyl terminus of the truncated receptor to facilitate protein analysis and designated as dnIGF-IR. To investigate the role of IGF-IR in lung cancer, we utilized the human lung adenocarcinoma A549 cells as our model system and stably expressed dnIGF-IR in A549 cells. Five clones (clone1, clone3, clone4, clone5 and clone12) which expressed similar levels of dnIGF-IR ( Figure 1a) and a pooled population of these ®ve clones (pool) were used to assess the biological eects of dnIGF-IR expression in A549 cells.
For initial characterization, we examined the physical and functional interactions of HA-tagged dnIGF-IR with the endogenous receptor. The endogenous IGF-IR was immunoprecipitated with an anti-HA antibody from cells expressing dnIGF-IR ( Figure  1b , lane 4) but not from control cells that were transfected with an empty vector (Figure 1b, lane 3) , indicating that the dnIGF-IR forms a heterocomplex with the wild type receptor. Nonspeci®c serum served as a negative control (Figure 1b, lanes 1 and 2) .
To determine if the dnIGF-IR could inhibit the function of the wild type receptor, we evaluated receptor phosphorylation by an in vitro kinase assay. IGF-I strongly stimulated phosphorylation of IGF-IR Figure 1 Characterization of dnIGF-IR-expressing cells. (a) Expression of HA-tagged-dnIGF-IR in A549 cells. A549 cells were transfected with a bicistronic vector (pBEFneo), or the pBEFneo vector containing dnIGF-IR cDNA. In the latter, the elongation factor 2 promoter was upstream of the dnIGF-IR cDNA and the neo r gene. Translation of the neo r gene was ensured by the presence of an internal ribosomal entry site between the two genes which share a common promoter and polyA signal. The transfected cells were selected with 0.4 mg/ml G418 in Ham's F12 medium (BioWhittaker). Equal amounts of total cellular proteins were resolved in 10% SDS ± PAGE and transferred onto nitrocellulose membrane followed by immunoblotting analysis using anti-HA antibody (Santa Cruz, CA, USA). Clones 1, 3, 4, 5, and 12 were expanded from G418-resistant colonies transfected with pBEFdnIGF-IR. (b) Physical interaction of dnIGF-IR with the endogenous IGF-IR. The vector control and dnIGF-IR-expressing (pool) cells were lysed in 1% NP-40 buer (50 mM Tris-HCI, pH 7.5, 150 mM NaCl, 5 mM EDTA, 1% NP-40, 1 mM PMSF) and cell lysates were precleared with normal rabbit serum (NRS) and protein A beads. The lysates were immunoprecipitated with either rabbit polyclonal anti-HA antibody or NRS. The immunoprecipitates were extensively washed and analysed by immunoblotting using rabbit anti-IGF-IR antibody. (c) Inhibition of the kinase activity of the endogenous IGF-IR by dnIGF-IR. Cells were starved in serum-free medium for 12 h and stimulated with 10 nM IGF-I for 15 min. Cell lysates were immunoprecipitated with anti-IGF-IR antibody. Half of the immunoprecipitates were subjected to in vitro kinase assay described previously (Liu et al., 1993) (upper panel) , and the other half were evaluated by Western blotting with anti-IGF-IR (bottom panel). (d) Inhibition of anchorageindependent growth of A549 cells by dnIGF-IR. The ®ve clones expressing dnIGF-IR and the vector control A549 cells were plated at a density of 1.5610 5 cells in 6-cm dishes containing 0.4% agar and maintained at 378C for 4 weeks for the growth of colonies. Colonies were stained with 50% INT solution (Sigma) in the vector control cells (Figure 1c, upper panel) . The IGF-I-stimulated kinase activity of the endogenous receptor in pooled dnIGF-IR cells was approximately twofold less than that in the control cells (Figure 1c , upper panel, lane 4 compared to lane 2, as quantitated by densitometer). Equal amounts of the wild type IGF-IR protein was immunoprecipitated and assayed in each cellular extract (Figure 1c, bottom panel) . Taken together, these data demonstrate that the dnIGF-IR can act as an inhibitor of endogenous IGF-IR.
To further ascertain the biological role of IGF-IR in transformation of A549 cells, we evaluated anchorageindependent growth and tumorigenicity in nude mice. The vector control cells and ®ve clones expressing dnIGF-IR ( Figure 1a ) were subjected to growth in 0.4% agar. The ®ve clones expressing dnIGF-IR formed small colonies in soft agar within four weeks (Figure 1d ). In contrast, the vector control cells formed signi®cantly higher numbers of colonies that grew to larger sizes. The number of large colonies (41 mm in diameter) in the dnIGF-IR cells was 50 ± 100-fold less than that in the vector control cells. Similar results were obtained from four independent experiments. However, no signi®cant dierences were observed when we compared the in vitro growth of vectortransfected A549 cells to the pooled dnIGF-IRexpressing cells in 2.5% fetal bovine serum (data not shown), probably due to the low level of expression of dnIGF-IR. It is possible that higher levels of expression of dnIGF-IR may be required for growth inhibition. On the other hand, mitogenicity and transformation are two important aspects of the malignant phenotype which may share common and distinct pathways. The hypothesis that mitogenicity and transformation can be segregated is supported by studies of the oncogenic tyrosine kinase v-Ros in which deletion of 6 amino acids near the catalytic loop retains wild type kinase activity and mitogenicity, but has dramatically reduced transforming activity (Zong et al., 1997) .
Next, we determined if inhibition by the dominantnegative receptor suppressed tumorigenicity of the lung adenocarcinoma cells in vivo. The vector control cells, two dnIGF-IR-expressing clones (clone 1 and clone 3) or the pooled population of dnIGF-IR-expressing cells were injected subcutaneously into athymic nude mice. The growth of the tumors was monitored and measured at weekly intervals. The vector control cells formed large tumors at 100% incidence (Table 1) . In contrast, the dnIGF-IR cells formed tumors at a lower incidence and when tumors developed, they grew to signi®cantly smaller sizes as determined by tumor volume and tumor weight. These results suggest that inhibition of the endogenous receptor by the dnIGF-IR can also suppress the tumorgenic phenotype in vivo.
To investigate the underlying mechanism of tumor suppression, we ®rst examined H & E staining of tumors resected from nude mice. Tumors derived from the A549 vector control cells were poorly dierentiated, disorganized and more cellular (Figure 2a, upper  panel) . In contrast, dnIGF-IR (pool) and clone 3 formed well-dierentiated glands with numerous central lumens. Similar results were obtained with dnIGF-IR clone 1 (data not shown). Since mucin production is characteristic of the normal respiratory epithelium, we examined mucin expression in these tumors by staining with mucicarmine. The tumor nodules recovered from the dnIGF-IR-expressing cells showed intracytoplasmic and intraluminal mucin staining (Figure 2a, middle panel) . In contrast, the tumors recovered from the vector control cells which lacked glandular structures had much less mucin staining, consistent with the less dierentiated phenotype of the tumors. To con®rm that expression of the HA-tagged dnIGF-IR promoted dierentiation of A549 cells, tumors derived from vector control, pooled dnIGF-IR clones and clone 3 were stained with anti-HA antibody. As shown in Figure 2a , 1996) . We examined whether the tumor suppressive eect of dnIGF-IR in A549 cells was due to induction of apoptosis in vivo. Tumors recovered from nude mice were stained by the TUNEL assay. Interestingly, no apoptotic cells were detected in the tumors derived from dnIGF-IR-expressing cells, but in contrast, numerous apoptotic cells were observed in the center of tumors derived from the vector control cells (Figure 2b ). The apoptotic center in the large tumors derived from control cells is probably due to poor vasculization, resulting in the nutrient deprivation and hypoxic conditions. Hence, the induction of apoptosis in vivo does not appear to be the mechanism of tumor suppression by dnIGF-IR in A549 cells.
IGF-IR has been previously shown to confer an anti-apoptotic eect when overexpressed in many cell types (Nakamura et al., 1997; Turner et al., 1997; D'Ambrosio et al., 1997; Resnico et al., 1996) . In addition, it has been reported that expression of a dominant-negative mutant of IGF-IR increases the sensitivity of 3T3 cells to apoptosis triggered by UV irradiation (Kulik et al., 1997) . To determined the sensitivity of dnIGF-IF-expressing cells to apoptotic signals, several apoptotic agents including UV irradiation and proteasome inhibitors were evaluated.
As shown in Figure 3a , the vector control cells displayed growth arrest within the ®rst three days and started to die on the fourth day following 1000 J/m 2 UV irradiation. However, the dnIGF-IR-expressing cells began to round up and exhibited membrane blebbling within 6 h after UV irradiation, and cell death was observed 24 h after irradiation. By the ®fth day following UV irradiation, none of the dnIGF-IRexpressing cells survived. The cell death caused by UV irradiation is due to apoptosis as detected by TUNEL assay (Figure 3b ). These results indicate that inhibition of the endogenous receptor by dnIGF-IR in A549 cells increases sensitivity to UV-induced apoptosis. Next, we examined the eects of dnIGF-IR expression on the sensitivity of A549 cells to apoptosis induced by the proteasome inhibitors N-acetyl-leucinylleucinyl-norleucinal (LLnL), aldehyde benzyloxycarbonyl-leucyl-leucyl-leucinal (Z-LLLaL) and lactacystin. Inhibition of proteasome by these inhibitors has been shown to trigger apoptosis (Imajoh-Ohmi et al., 1995; Shinihara et al., 1996) . LLnL and Z-LLLaL inhibit both calpain and proteasome activities in vitro which lactacystin is a more speci®c inhibitor of proteasome. The vector control and pooled dnIGF-IR-expressing cells were treated with LLnL (50 mM) (Figure 4a ). Beginning at 24 h after treatment and up to 72 h following treatment, there was a progressive increase in the percentage of dnIGF-IR-expressing cells that underwent apoptosis, whereas with the same dose of LLnL treatment at each time point, the vector control cells appeared to be resistant to the induction of apoptosis. Similarly, treatment of the dnIGF-IRexpressing cells with lactacystin (50 mM) resulted in apoptosis as early as 24 h (Figure 4b) . Finally, ZLLLaL also induced apoptosis in the dnIGF-IRexpressing cells in a dose-dependent manner ( Figure  4c ). When the concentration of Z-LLLaL was Figure 2 Induction of glandular dierentiation of A549 cells by dnIGF-IR. (a) In upper panel, glandular dierentiation was detected using hematoxylin and eosin (H&E) staining. Tumors were resected from nude mice 35 days after injection and ®xed in 10% formaldehyde for preparation of paran embedded slides which were stained with H&E. In middle panel, mucicarmine production was detected in dierentiated tumor samples. Tumors were resected from nude mice 18 days after injection and stained for mucin (red) using mucicarmine staining kit (Sigma). In bottom panel, dnIGF-IR is expressed in tumors recovered from nude mice 18 days after injection. The slides were stained with monoclonal anti-HA antibody. (b) Detection of apoptosis in vivo in tumor samples. Paran slides prepared from tumor samples were assayed for apoptosis by TUNEL staining (Promega, WI, USA) increased to 3 and 4 mM, higher numbers of apoptotic cells were detected in the dnIGF-IR-expressing cells, reaching 100% with 4 mM of Z-LLLaL at 72 h. No apoptotic cells were detected in vector control cells treated with the same doses of Z-LLaL for the same duration. Taken together, inhibition of the endogenous IGF-IR by the dnIGF-IR signi®cantly increases the sensitivity of A549 cells to various apoptotic stimuli.
In accord with previous studies, we have con®rmed the importance of IGF-IR in the establishment and maintenance of cell transformation and tumorgenic phenotype. The experiments described in this study establish the novel ®nding that inhibition of IGF-IR in A549 cells induced glandular dierentiation in vivo which substantiates the observation that induced dierentiation repressed malignancy. Hence, induction of tumor cell dierentiation may underlie the tumor suppressive eect of dnIGF-IR. Consistent with paracrine control of dierentiation, a partially purified factor isolated from ®broblast conditioned medium has been shown to inhibit the growth of A549 cells as established xenografts in nude mice and induce stromal in®ltration and glandular-like or duct-like differentiation (Speirs et al., 1991) . In spite of its transformed phenotype, A549 cells can still respond to paracrine control of dierentiation via a soluble factor. It is unlikely that this factor is IGF-I because inhibition of IGF-IR function by expression of dnIGF-IR promoted dierentiation. It is conceivable that dierentiation is controlled by both positive-acting and negative-acting factors. Our results suggest that the role of IGF-I in the dierentiation of A549 cells may be inhibitory and hence, a critical threshold level of IGF-IR signaling is required to suppress cellular dierentiation and maintain the transforming phenotype. Although the exact mechanism by which IGF-IR signaling regulates mitogenic versus dierentiation signals is not well de®ned, our data suggest that it plays a key role in regulating cellular transformation and dierentiation.
In addition, a pivotal role for IGF-mediated signaling in the survival of tumor cells has also been demonstrated. Previous studies have suggested that 5 cells were plated in 6-well plates. Cells were irradiated with 1000 J/m 2 UV using a UV crosslinker (Stratagene, LaJolla, CA, USA) and viable cells were counted daily. The curve represents three independent experiments. (b) Detection of apoptosis of the dnIGF-IR-expressing cells irradiated with UV. The control and dnIGF-IR (pool) cells were UVirradiated at a dose either 500 J/m 2 or 1000 J/m 2 followed by TUNEL assay for detection of apoptosis IGF-IR is capable of protecting cells from apoptotis induced by a number of insults. For example, activation of IGF-IR inhibits tumor necrosis factor alpha-induced cell death and overexpression of the receptor prevents UV irradiation-induced apoptosis and enhances neuroblastoma tumorigenesis (Singleton et al., 1996; Wu et al., 1996; Kulik et al., 1997) . Thus, inhibition of the function of the wild type receptor by expression of the dominant-negative mutant receptor renders tumor cells more susceptible to apoptotic signals (Kulik et al., 1997) . Interestingly, the domains of IGF-IR that are involved in the protection against apoptosis are distinct from those involved in transformation and mitogenicity (O'Connor et al., 1997) . Nontransforming mutants of IGF-IR are capable of suppressing apoptosis. These data suggest that the apoptosis-protecting domains may be necessary but not sucient for cell transformation. In vivo apoptosis described by D' Ambrosio et al. (1996) appears to be at least one of the mechanism of tumor suppression caused by expression of a dominant-negative mutant of the IGF-IR. However, we found that expression of dnIGF-IR in A549 cells does not cause spontaneous apoptosis in vivo at various times during tumor growth in nude mice (18 and 35 days). The tumor suppressive eect of dnIGF-IR in A549 cells is probably not due to the induction of apoptosis or dierences in growth kinetics in vivo because no signi®cant dierences in cell growth was observed in vitro in high or reduced serum (data not shown). Our data supports the induction of cell dierentiation as the mechanism of tumor suppression in vivo. We have demonstrated that expression of dnIGF-IR also increases the sensitivity of A549 cells to apoptosis-inducing signals including UV irradiation and treatment with proteasome inhibitors. A549 cells expressing dnIGF-IR are also more sensitive to killing by the chemotherapeutic agent taxol (data not shown). It is possible that the enhanced sensitivity to apoptosis-inducing signals may be due to a decrease in the threshold level in response to death signals. Hence, it is possible to exploit the latter to decrease toxicity of chemotherapy while increasing ecacy.
In conclusion, our results further support the development of anti-cancer therapies based on antagonizing IGF-IR signaling to suppress tumor growth and enhance sensitivity to apoptosis-inducing agents such as radiation and chemotherapeutic drugs. Impairment of survival factor function of IGF-IR signaling may allow the use of lower doses of chemotherapy or radiation therapy with reduced toxicity. Hence, the future development of speci®c and ecient inhibitors of IGF signaling will be valuable for combination therapy to potentiate the ecacy of chemotherapy and radiation therapy. 
